| Recruiting | Point of Care - Triage and Treatment for Cervical Pre-cancer NCT07461818 | Basic Health International, Inc. | N/A |
| Recruiting | Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine NCT07275333 | Karolinska Institutet | N/A |
| Not Yet Recruiting | Study on Novel Strategies for Cervical Cancer Screening Using Photoelectric Detection and Epigenetic Procotol NCT06866392 | Peking Union Medical College Hospital | — |
| Recruiting | Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer NCT06815939 | DL Analytics | N/A |
| Active Not Recruiting | A Novel, Low-Cost, Handheld 3D Imaging System for Improved Screening for Cervical Neoplasia in Resource-Limite NCT06810427 | Carilion Clinic | N/A |
| Recruiting | Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma NCT06191133 | Lindsay Ferguson, MD | Phase 1 |
| Active Not Recruiting | Comparisons of the Effects and Clinical Outcomes of CH2 Vaginal Gel Versus Placebo on CIN1 NCT06582004 | National Taiwan University Hospital | N/A |
| Not Yet Recruiting | Cervical Cytology DNA Methylation for Cervical Cancer Screening NCT06557954 | Lei Li | — |
| Completed | Cervical Intraepithelial Neoplasia Screening Using Liquid-Based Pap Smear Among Egyptian Women NCT07250841 | Kasr El Aini Hospital | — |
| Not Yet Recruiting | A Multicenter Randomized Controlled Study of Photoelectric Detection in Cervical Cancer Screening NCT06491888 | Lei Li | N/A |
| Enrolling By Invitation | Efficacy of Topical 85% TCA in the Treatment of LSIL After Low-grade Abnormality of Screening Test: a Randomiz NCT06525870 | Department of Medical Services Ministry of Public Health of Thailand | Phase 2 |
| Completed | Cervical Cancer Screening of Postmenopausal Women in Low- and Middle-income Countries Using HPV Self-sampling NCT07244315 | University Hospital, Geneva | — |
| Active Not Recruiting | Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolesc NCT06243666 | Xiamen University | — |
| Active Not Recruiting | Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSel NCT05996783 | Universiteit Antwerpen | N/A |
| Completed | Dry Run of the ScreenUrSelf Trial NCT05996796 | Universiteit Antwerpen | N/A |
| Recruiting | Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV NCT05266898 | Louisiana State University Health Sciences Center in New Orleans | Phase 4 |
| Not Yet Recruiting | Diagnostic Cervical Conization for Persistent Infection or Integration of HPV NCT05510830 | Tongji Hospital | N/A |
| Terminated | A Study of ABI-2280 Vaginal Insert (Previously Referred to as ABI-2280 Vaginal Tablet) in Participants With Ce NCT05502367 | Antiva Biosciences | Phase 1 / Phase 2 |
| Completed | A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy NCT05496231 | GlaxoSmithKline | Phase 1 / Phase 2 |
| Recruiting | Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment NCT05405270 | Catharina Ziekenhuis Eindhoven | — |
| Recruiting | Effect of HPV Integration on Prognosis of Young Women With CIN2 in China NCT05282095 | Fujian Maternity and Child Health Hospital | — |
| Unknown | Cervical Cancer Screening Strategies NCT05309122 | Lei Li | — |
| Unknown | DNA PAX1 and JAM3 Methylation for Cervical Cancer Screening NCT05290428 | Peking Union Medical College Hospital | — |
| Recruiting | The Organ Transplant Recipient HPV and Skin Cancer Study NCT05284877 | Merete Haedersdal | — |
| Recruiting | Low-cost Imaging Technology for Global Prevention of Cervical Cancer NCT05078528 | Barretos Cancer Hospital | N/A |
| Unknown | The Dynamic Process of VMB and Mucosal Immunity After FUS Treatment of CIN Patients With Fertility Requirement NCT05142397 | Shufang Chang | — |
| Recruiting | Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia NCT04712851 | Jonsson Comprehensive Cancer Center | Phase 2 |
| Unknown | The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Femal NCT05045755 | Jun Zhang | — |
| Unknown | The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female NCT04969445 | Jun Zhang | — |
| Unknown | Vvax001 Cancer Vaccine in Premalignant Cervical Lesions - Phase II NCT06015854 | University Medical Center Groningen | Phase 2 |
| Recruiting | Conservative Management of HSIL in Patients With Future Pregnancy Aspiration NCT04783805 | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | — |
| Unknown | Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls ( NCT04704908 | Jun Zhang | — |
| Not Yet Recruiting | Impact on Disease Relapse of HPV Vaccination in Women Treated With LEEP for Cervical Intraepithelial Neoplasia NCT03848039 | Alessandro Ghelardi | Phase 3 |
| Unknown | DNA Methylation Testing for the Screening of Uterine Cervical Lesion NCT04646954 | Lei Li | Phase 3 |
| Unknown | Immunohistochemical Staining of p16 for the Screening of Cervical Cancer NCT04650711 | Lei Li | Phase 2 |
| Recruiting | HPV-based Screening Among Women 23-29 Years of Age NCT05229679 | Karolinska Institutet | N/A |
| Completed | Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device NCT03429582 | The Cleveland Clinic | N/A |
| Active Not Recruiting | Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,5 NCT04537156 | Xiamen University | Phase 3 |
| Completed | CASUS: Validation for Detection of Precursor Lesions NCT04530201 | Universiteit Antwerpen | N/A |
| Withdrawn | E7 TCR T Cell Immunotherapy for High-Grade Cervical Intraepithelial Neoplasia NCT04411134 | National Cancer Institute (NCI) | Phase 1 |
| Enrolling By Invitation | Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies NCT04266093 | National Cancer Institute (NCI) | — |
| Completed | Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female NCT05426148 | Xiamen Innovax Biotech Co., Ltd | Phase 4 |
| Recruiting | Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia NCT06611020 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | — |
| Completed | CASUS: Improved and Quality Assured Collection of First-void Urine NCT04480866 | Universiteit Antwerpen | N/A |
| Unknown | Safety and Efficacy of Laser Therapy in Gynaecology NCT04073082 | Juna d.o.o. | — |
| Unknown | DC Vaccines Targeting HPV16/18 E6/E7 Protein to Regress CINI/CIN2 NCT03870113 | Shenzhen People's Hospital | Phase 1 |
| Unknown | A Efficacy and Safety Study of Composite Gel Containing Black Raspberry Extract in Removing HPV From Patients NCT03745846 | Tianjin Medical University Cancer Institute and Hospital | Phase 2 |
| Completed | Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed ( NCT03629886 | GlaxoSmithKline | Phase 4 |
| Completed | A Post Marketing Surveillance (PMS) Study to Monitor the Safety of GlaxoSmithKline (GSK) Biologicals' Human Pa NCT03438006 | GlaxoSmithKline | — |
| Completed | A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in NCT03355820 | GlaxoSmithKline | Phase 3 |
| Completed | Local Hyperthermia for the Treatment of Cervical Intraepithelial Neoplasias NCT03436251 | First Hospital of China Medical University | N/A |
| Completed | Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infec NCT03239223 | Antiva Biosciences | Phase 1 |
| Unknown | TMTP1-ICG Mapping in Colposcopy-directed Biopsy NCT03321461 | Huazhong University of Science and Technology | Phase 1 |
| Withdrawn | Study of SOR007 Ointment for Cervical Intraepithelial Neoplasia (CIN) NCT03143491 | DFB Soria, LLC | Phase 2 |
| Completed | Physical Cold Atmospheric Plasma for the Treatment of Cervical Intraepithelial Neoplasia NCT03218436 | University Hospital Tuebingen | N/A |
| Completed | An Innovative Treatment for Cervical Precancer (UH3) NCT03084081 | The Cleveland Clinic | N/A |
| Completed | Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls NCT03206255 | Jun Zhang | — |
| Unknown | Longitudinal HPV Pap in CIN and VAIN NCT05931354 | Chang Gung Memorial Hospital | — |
| Completed | E7 TCR T Cells for Human Papillomavirus-Associated Cancers NCT02858310 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | FASTER-Tlalpan Study in Mexico: HPV Vaccination Impact on Cervical Cancer Screening Program NCT03105856 | Instituto Nacional de Salud Publica, Mexico | Phase 4 |
| Completed | Incidence of Cervical Cancer in HPV-positive Women With Low-grade Cytological Abnormalities NCT07259616 | Gynaecologisch Oncologisch Centrum Zuid | — |
| Unknown | Imiquimod Treatment of High-grade CIN NCT02917746 | Maastricht University Medical Center | N/A |
| Completed | Impact of HPV Vaccine On The Prevalence Of HPV In Norway NCT02934724 | Oslo University Hospital | — |
| Completed | Testing Use of Condoms on Regression of Cervical Intraepithelial Neoplasia NCT02907333 | University of Copenhagen | N/A |
| Completed | Participation in Screening for Cervical Cancer: Interest of a Self-sampling Device Provided by the General Pra NCT02749110 | University Hospital, Lille | N/A |
| Completed | Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3) NCT02864147 | Yale University | Phase 2 |
| Unknown | Imiquimod Treatment of Residual or Recurrent CIN Lesions: a Study Protocol NCT02669459 | Erasmus Medical Center | Phase 3 |
| Completed | Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1) NCT02631863 | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | Phase 2 |
| Completed | Evaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females NCT02740777 | Shanghai Zerun Biotechnology Co.,Ltd | Phase 2 |
| Completed | An Innovative Treatment for Cervical Pre Cancer NCT02814448 | The Cleveland Clinic | N/A |
| Completed | A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls NCT02562508 | Jun Zhang | Phase 3 |
| Completed | A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesio NCT02481414 | University of Arkansas | Phase 2 |
| Completed | HRME: Screening for Cervical Cancer and Its Precursors in Low-Resource Settings NCT02494310 | Barretos Cancer Hospital | N/A |
| Unknown | HPV Integration Testing for Human Papillomavirus-Positive Women NCT02576262 | Huazhong University of Science and Technology | — |
| Unknown | Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Plasmid DNA Therapeutic Vaccine(GX-188E) NCT02596243 | Genexine, Inc. | Phase 2 |
| Withdrawn | Effect of Curcumin in Treatment of Squamous Cervical Intraepithelial Neoplasias (CINs) NCT02554344 | Baylor Research Institute | EARLY_Phase 1 |
| Completed | Hemodynamic Stability of Bupivacaine With and Without Adrenaline for Paracervical Block for Cervical Conizatio NCT02368054 | Helse Fonna | Phase 4 |
| Unknown | HPV Integration Testing for Cervical Cancer Screening NCT02576158 | Huazhong University of Science and Technology | — |
| Completed | Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix NCT02130323 | United States Naval Medical Center, San Diego | Phase 2 / Phase 3 |
| Completed | Music Listening to Reduce Pain and Anxiety During LEEP NCT02398916 | Chiang Mai University | N/A |
| Active Not Recruiting | Compass - Randomised Controlled Trial of Primary HPV Testing for Cervical Screening in Australia NCT02328872 | VCS Foundation | N/A |
| Completed | Aminolaevulinic Acid Photodynamic Therapy of Cervical Persistent HPV Infection and Cervical Neoplasia NCT02304770 | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | Phase 2 |
| Unknown | The Efficacy of Tachosil® for Prevention of Hemorrhage After Loop Electrosurgical Excisional Procedure (LEEP) NCT02629510 | Asan Medical Center | Phase 4 |
| Terminated | Imiquimod Treatment of CIN Lesions NCT02329171 | Maastricht University Medical Center | Phase 3 |
| Completed | A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine. NCT02733068 | Shanghai Zerun Biotechnology Co.,Ltd | Phase 3 |
| Terminated | Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervi NCT02140021 | M.D. Anderson Cancer Center | N/A |
| Completed | Comparing Two Techniques of Haemostasis After Cervical Conization NCT03293628 | Barretos Cancer Hospital | Phase 2 |
| Completed | Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia NCT02139267 | Genexine, Inc. | Phase 2 |
| Completed | Efficacy and Safety Study of BLS_ILB_E710c for the Fertile Women With Cervical Intraepithelial Neoplasia(CIN3) NCT02195089 | BioLeaders Corporation | Phase 1 / Phase 2 |
| Unknown | DNA Methylation Biomarkers for Cervical Cancer Screening NCT02605941 | iStat Biomedical CO., Ltd. | — |
| Unknown | Retrospective Study on the Evolution of CIN 1 to 3 in Per and Postpartum in Nancy From 2014 to 2022 NCT05595252 | Central Hospital, Nancy, France | — |
| Completed | Efficacy and Safety Study of PGA (Poly-gamma Glutamic Acid) for Cervical Intraepithelial Neoplasia NCT01826045 | BioLeaders Corporation | Phase 2 |
| Unknown | Phase I, Open-Label Study of the Safety, Tolerability, and Immunogenicity PEK Fusion Protein Vaccine NCT01880411 | HealthBanks Biotech Co., Ltd. | Phase 1 |
| Terminated | Topical Imiquimod Versus Conization to Treat Cervical Intraepithelial Neoplasia NCT01283763 | Medical University of Vienna | Phase 3 |
| Completed | HPV Genotyping by DR. HPV Genotyping in Vitro Diagnostic Device (IVD) Kit in Exfoliated Cells of the Uterine C NCT04333212 | Chang Gung Memorial Hospital | N/A |
| Completed | Improving Cervical Cancer Screening Among HIV-Infected Women in India NCT02247999 | National Cancer Institute (NCI) | — |
| Completed | Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent（Type 16/18 ）Vaccine NCT01735006 | Xiamen University | Phase 3 |
| Completed | Study of the Diagnostic Efficacy of "Real Time" Niris 1300e Optical Coherence Tomography (OCT) Imaging System NCT01766284 | Preventive Oncology International, Inc. | N/A |
| Completed | Evaluation of Human Papilloma Virus (HPV) Self-testing to Increase Screening Uptake NCT02095561 | Instituto Nacional del Cáncer, Argentina | N/A |
| Completed | V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110) NCT01544478 | Merck Sharp & Dohme LLC | Phase 4 |
| Completed | Chinese Cancer Prevention Study(CHICAPS) NCT01524003 | Preventive Oncology International, Inc. | N/A |
| Unknown | Prevaccination Study of Cervical Human Papillomavirus Types in Yangtze River Delta Area, China NCT01487681 | Xing Xie, MD | — |
| Completed | Visual Inspection With Acetic Acid Compared to Lugol's Iodine in HIV-infected Women NCT02237326 | University of California, San Francisco | N/A |
| Completed | Cryotherapy vs. LEEP to Treat Cervical Intraepithelial Neoplasia (CIN) 2/3 Among HIV-positive Women NCT01298596 | University of Washington | N/A |
| Completed | The Development of a "Mother/Child, Screen, Treat and Vaccinate Program" in Manchay and Iquitos, Peru NCT01338051 | Preventive Oncology International, Inc. | Phase 1 |
| Completed | Clinical Evaluation of Polarized Light Assisted Colposcopy NCT01349621 | Augusta University | — |
| Completed | A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade NCT01304524 | Inovio Pharmaceuticals | Phase 2 |
| Completed | Dose-finding Study of Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) to Treat Cervical Neoplasia NCT01256424 | Photocure | Phase 2 |
| Completed | Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine NCT01356823 | Xiamen University | Phase 2 |
| Unknown | HPV-cytology Testing Versus Cytology Testing for the Detection of High Grade CIN NCT01058460 | The University of Hong Kong | N/A |
| Terminated | An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+ NCT01116245 | Advaxis, Inc. | Phase 2 |
| Unknown | Randomized Trial of Vaginal Self Sampling for Human Papillomavirus (HPV) NCT01095198 | McMaster University | Phase 2 / Phase 3 |
| Completed | Validation of Implementation of Cervical Dysplasia Treatment Modalities in HIV-Seropositive Women NCT01723956 | University of Witwatersrand, South Africa | N/A |
| Completed | Trial to Evaluate Single- and Double- Freeze Cryotherapy in the Prevention of Cervical Neoplasia NCT01145781 | Tata Memorial Hospital | N/A |
| Completed | A Comparison Study of Two Community Outreach-Based Approaches to Increase Participation of Women Living in the NCT01058148 | National Cancer Institute (NCI) | — |
| Completed | Randomized Controlled Trial to Study Interventions to Increase Participation in Cervical Cancer Screening Prog NCT01029990 | Göteborg University | EARLY_Phase 1 |
| Completed | A Study of RO5217790 in Participants With High Grade Cervical Intraepithelial Neoplasia (CIN) Associated With NCT01022346 | Hoffmann-La Roche | Phase 2 |
| Completed | Human Papillomavirus Epidemiology in Nigeria NCT00804466 | National Cancer Institute (NCI) | N/A |
| Completed | ITIC (Imiquimod Therapy in Cervical Intraepithelial Neoplasia)-Trial NCT00941252 | Medical University of Vienna | Phase 2 / Phase 3 |
| Completed | Indirect Comparison Topotecan Cervical Carcinoma NCT01345279 | GlaxoSmithKline | — |
| Completed | Meta-analysis of Efficacy of Topotecan NCT01160185 | GlaxoSmithKline | — |
| Completed | Cold Knife Conization With and Without Lateral Hemostatic Sutures NCT02184975 | Barretos Cancer Hospital | Phase 2 |
| Terminated | Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1 NCT00708942 | Photocure | Phase 2 |
| Terminated | Evaluation of Initial High Risk Human Papillomavirus (HR-HPV) Viral Load as Predictive Marker for Cervical Int NCT00682552 | Assistance Publique Hopitaux De Marseille | N/A |
| Completed | Randomized Clinical Trial on Clinical Management of ASCUS and LSIL (ALTS) NCT01131312 | National Cancer Institute (NCI) | Phase 3 |
| Completed | Quality of Life in Thai Women Diagnosed Cervical Cancer at King Chulalongkorn Memorial Hospital NCT00741533 | Chulalongkorn University | — |
| Completed | A Trial of Two Electrosurgical Conizations: Histopathological Analysis of Excision Margins NCT01929993 | Oswaldo Cruz Foundation | Phase 3 |
| Completed | A Two-Stage Phase 2 Study Of A-007 Topical Gel in High-Grade Squamous Intraepithelial Lesions (HSIL) NCT00596258 | Tigris Pharmaceuticals | Phase 2 |
| Unknown | Safety Study to Test the Safety of HspE7 and Poly-ICLC Given in Patients With Cervical Intraepithelial Neoplas NCT00493545 | Nventa Biopharmaceuticals Corporation | Phase 1 |
| Completed | Human Papillomavirus (HPV) Testing to Improve Cervical Cancer Screening in the Mississippi Delta NCT00443313 | National Cancer Institute (NCI) | — |
| Completed | Comparison of Human Papillomavirus Integrated DNA and Messenger RNA in Cervical Neoplasia NCT02198365 | Cathay General Hospital | — |
| Completed | Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women NCT00337818 | GlaxoSmithKline | Phase 3 |
| Completed | Factors Associated With Residual Disease In The Central Cone NCT03788850 | National Institute of Cancerología | — |
| Completed | Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL NCT00285207 | Tigris Pharmaceuticals | Phase 2 |
| Unknown | The Correlations Between HPV L1-Specific Immunologic Responses in Cervical Cancer and Cervical Intraepithelial NCT00728871 | National Taiwan University Hospital | N/A |
| Completed | Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio NCT00316706 | GlaxoSmithKline | Phase 3 |
| Completed | A Trial for Patients With Advanced/Recurrent Cervical Cancer NCT00190983 | Eli Lilly and Company | Phase 2 |
| Completed | A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia NCT00154089 | Erimos Pharmaceuticals | Phase 1 / Phase 2 |
| Completed | Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and II NCT00247169 | Medical University of Vienna | Phase 2 |
| Completed | Management of Cervical Intraepithelial Neoplasia Grade 2 NCT00733109 | Universidade Cidade de Sao Paulo | Phase 4 |
| Completed | Use of Human Papillomavirus Persistence for Determination of Treatment Efficacy Among Women With Cervical Dysp NCT00931190 | Lund University | — |
| Completed | Recurrence in High-grade Lesions After Conization NCT02540421 | Faculdade de Medicina do ABC | — |
| Completed | Immediate Treatment vs Colposcopic Follow-up for Biopsy-Proven CIN 1 NCT00156026 | Ontario Clinical Oncology Group (OCOG) | Phase 3 |
| Completed | Efficacy Study of Diathermy Cone Biopsy for the Treatment of Cervical Intraepithelial Lesion NCT00995020 | Oswaldo Cruz Foundation | Phase 3 |
| Completed | Feasibility of the Management of Severe Cervical Dysplasia in a Single Visit NCT00237562 | University of California, Irvine | Phase 3 |
| Completed | Randomized Controlled Trial of Human Papillomavirus Testing in Primary Cervical Cancer Screening NCT00479375 | Skane University Hospital | N/A |